NCT03073200 Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03057977 EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) Status COMPLETED Phase PHASE3
NCT03057951 EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) Status COMPLETED Phase PHASE3
NCT03057145 Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03056456 A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump Status COMPLETED Phase PHASE1
NCT03053622 A Study of Mirikizumab (LY3074828) Injection in Healthy Participants Status COMPLETED Phase PHASE1
NCT03050229 SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study) Status COMPLETED Phase PHASE4
NCT03040479 Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function Status COMPLETED Phase PHASE1
NCT03040362 Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration Status COMPLETED Phase PHASE1
NCT03031938 Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies Status COMPLETED Phase PHASE3
NCT03027284 A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT03019549 A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin Status COMPLETED Phase PHASE1
NCT03019536 A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT03018938 A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4